Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
Siwa Therapeutics

Organization & Developments: Siwa Therapeutics

Parents

*Biopharmaceutical company focused on developing therapies that target senescent cells and cancer.
*Lead compound, SIWA318H, is an antibody that targets advanced glycation end products (AGEs), which are associated with aging and cancer progression.
*Research conducted by SIWA Therapeutics, in collaboration with the Translational Genomics Research Institute (TGen), could be crucial in treating aggressive cancers like pancreatic ductal adenocarcinoma (PDAC).